Medline Inc (MDLN) PT Lowered to $45 at Barclays, 'Material input costs are the biggest swing factor in F26'
Barclays analyst Glen Santangelo lowered the price target on Medline Inc (NASDAQ: MDLN) to $45.00 (from $50.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)